Medical News

  • Reports warn of growing opioid crisis among seniors
    (HealthDay)—Against the backdrop of an unrelenting opioid crisis, two new government reports warn that America's seniors are succumbing to the pitfalls of prescription painkillers. Read more »
  • Acupuncture: A new look at an ancient remedy
    (HealthDay)—Widely practiced in Asia for thousands of years, acupuncture is one of the key components of traditional Chinese medicine. Yet it's still viewed with some skepticism in the Western world. Read more »
  • Infants can use a few labeled examples to spark the acquisition of object categories
    Even before infants begin to speak, hearing language promotes object categorization. Hearing the same label, "That's a dog!" applied to a diverse set of objects—a collie, a terrier, a pug—promotes infants' acquisition of object categories (e.g., the category "dog"). But in infants' daily lives, most objects go unlabeled. Infants are constantly seeing new things, and even the most determined caregivers cannot label each one. Read more »
  • Study reveals Arizona EMTs face 39-percent greater risk of suicide
    Arizona emergency medical technicians' risk for suicide is 39-percent higher than the general public, according to a new study conducted by University of Arizona College of Medicine—Phoenix researchers. Read more »
  • Women who breastfeed for at least five months have more kids
    Women who breastfeed their first child for five months or longer are more likely to have three or more children, and less likely to have only one child, than women who breastfeed for shorter durations or not at all. Read more »
  • People can handle the truth (more than you think)
    Most people value the moral principle of honesty. At the same time, they frequently avoid being honest with people in their everyday lives. Who hasn't told a fib or half-truth to get through an awkward social situation or to keep the peace? Read more »
  • Characterization of pregnancy microbiome reveals variations in bacterial diversity
    The collection of an estimated 100 trillion resident microorganisms of the human body, termed the human microbiome, contributes to the physiology of human health and disease including nutrition, immune function, metabolism, and development. Recent studies suggest that the maternal microbiome changes composition during gestation and may be associated with pre-term birth. Yet, there remains a lack of detailed analyses regarding the structure, function, and temporal dynamics of the maternal microbiome and how it contributes to gestational outcome and fetal development. Read more »
  • Zombie cells found in brains of mice prior to cognitive loss
    Zombie cells are the ones that can't die but are equally unable to perform the functions of a normal cell. These zombie, or senescent, cells are implicated in a number of age-related diseases. And with a new letter in Nature, Mayo Clinic researchers have expanded that list. Read more »
  • Administration sends states $1B in grants to battle opioids
    The Trump administration is awarding more than $1 billion in grants to help states confront the opioid epidemic, with most of the money going expand access to treatment and recovery services. Read more »
  • Researchers discover influenza virus doesn't replicate equally in all cells
    The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year. In order to better understand this virus and how it spreads, University of Minnesota Medical School researchers took a closer look at the cells inside the lungs. What they discovered is not only is the immune system response tuned to the amount of virus replication, it's also tuned to the viral spread. This deeper and more accurate understanding of the influenza virus and how it spreads could be the building blocks to better protective therapies for patients in the future. Read more »
  • Newborn opioid withdrawal requires a 'cascade of care,' study suggests
    Effective management of neonatal abstinence syndrome (NAS) - withdrawal symptoms occurring in infants exposed to opioids in utero - requires a coordinated "cascade of care" from prevention through long-term follow-up, reports a study in Advances in Neonatal Care. Read more »
  • Strategies to protect bone health in hematologic stem cell transplant recipients
    Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for many patients with malignant and non-malignant hematological diseases, such as leukemia and multiple myeloma. The success of recent advances in such transplantation techniques and supportive care measures, has led to greater numbers of long-term HSCT survivors. Read more »
  • Plasticity is enhanced but dysregulated in the aging brain
    They say you can't teach old dogs new tricks, but new research shows you can teach an old rat new sounds, even if the lesson doesn't stick very long. Read more »
  • More doctor visits lead to less suicide attempts for fibromyalgia patients
    Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research. Read more »
  • Anti-inflammatory protein promotes healthy gut bacteria to curb obesity
    Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes, both of which are risk factors for cardiovascular disease and other serious conditions. Read more »
  • Bascom Palmer treats first US patient in Nightstar gene therapy
    A Puerto Rican patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. On August 23, Julio Adorno Nieves, 23, became the first U.S. patient to be given new genes for his inherited blinding condition in a worldwide Nightstar Therapeutics clinical trial. Read more »
  • Rumors, conflict challenge Ebola response in eastern Congo
    The latest Ebola outbreak in Congo presents complex challenges as the virus spreads for the first time in an area where long-running conflict is hampering aid efforts, the regional Africa chief for the International Federation of the Red Cross said Wednesday. Read more »
  • Flu shots: A pinch in the arm, but not always in your wallet
    It's flu shot season, but the pinch of a shot doesn't have to also hurt your wallet. Read more »
  • New insights into the way the brain combines memories to solve problems
    Humans have the ability to creatively combine their memories to solve problems and draw new insights, a process that depends on memories for specific events known as episodic memory. But although episodic memory has been extensively studied in the past, current theories do not easily explain how people can use their episodic memories to arrive at these novel insights. Read more »
  • CTLA4 targeted therapy plus PD-1 targeted therapy could benefit women with ovarian cancer
    An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer. These results were presented as a late-breaking abstract oral presentation at the 17th Biennial Meeting of the International Gynecological Cancer Society (IGCS) in Kyoto, Japan. This trial was sponsored by the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI) and the agents were provided to NCI by Bristol Myers Squibb under the cooperative research and development agreements between Bristol Myers Squibb and NCI for the development of nivolumab and ipilimumab. Read more »
Pin It